Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00684359 · ClinicalTrials.gov registry record
Platelet Reactivity After Cessation of Clopid in the Setting of Coronary Stent Implantation I: PRACTICE I
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 30
- Enrollment target
NCT00684359 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 30 participants.
The verdict
NCT00684359 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Single center randomized parallel group study to determine if: 1. there is a temporary increase in platelet reactivity after abrupt discontinuation of clopidogrel due to a potential rebound phenomenon. 2. the effect of sudden discontinuation of clopidogrel 6 months post coronary angioplasty with adjunct drug eluting stent implantation compared to 12 month continuation of clopidogrel on platelet reactivity. And the association with MACE up to 12 months post coronary angioplasty.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00684359
The ClinicalTrials.gov registry entry for NCT00684359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00684359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00684359 about?
NCT00684359 is a clinical study titled "Platelet Reactivity After Cessation of Clopid in the Setting of Coronary Stent Implantation I: PRACTICE I". Single center randomized parallel group study to determine if: 1. there is a temporary increase in platelet reactivity after abrupt discontinuation of clopidogrel due to a potential rebound phenomenon. 2. the effect of sudden discontinuation of clopidogrel 6 months post coronary angioplasty with ad...
What is the current status of trial NCT00684359?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2007-06. Estimated completion is 2010-02.
Who is sponsoring clinical trial NCT00684359?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.